Effects of 1 to 3 years' treatment with
โ
David B. Burr; Tamim Diab; Andrew Koivunemi; Mark Koivunemi; Matthew R. Allen
๐
Article
๐
2009
๐
Elsevier Science
๐
English
โ 78 KB
๐ 2 views
## Abstract Bisphosphonate (BP) treatment used to prevent bone loss in postmenopausal osteoporosis has recently been implicated in an apparent increase in subtrochanteric femoral fractures. Previous work showed that BPs can reduce the energy to fracture of cancellous bone, but limited data exist on